.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Expert Perspectives on the Management of Chronic Myeloid Leukemia

EP. 1: Mutation Analysis in Chronic Myeloid Leukemia

January 14th 2016

EP. 2: Clinical Goals of Treating CML

January 14th 2016

EP. 3: Upfront Treatment of Chronic Myeloid Leukemia CML

January 14th 2016

EP. 4: Measuring Response in Chronic Myeloid Leukemia Treatment

January 14th 2016

EP. 5: Importance of Monitoring Patients with Chronic Myeloid Leukemia

January 14th 2016

EP. 6: Bone Marrow Assessment in CML Management

January 14th 2016

EP. 7: Chronic Myeloid Leukemia Treatment Discontinuation

January 14th 2016

EP. 8: Managing Toxicities from CML Treatment

January 14th 2016

EP. 9: Switching Therapy in Chronic Myeloid Leukemia

January 14th 2016

EP. 10: Stem Cell Transplant in Chronic Myeloid Leukemia

January 14th 2016

EP. 11: Case Study: Selecting a Tyrosine Kinase Inhibitor in CML

January 14th 2016

EP. 12: Closing Thoughts on Managing Chronic Myeloid Leukemia

January 14th 2016